E. David Crawford, MD | Authors

WAL MART PHARMACY

250 E TUCKER RD

Articles

Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer

April 19, 2021

ONCOLOGY® editorial board member E. David Crawford, MD, and colleagues, propose a new model for guiding the treatment of prostate cancer that focuses on a “transitional state,” which occurs during the interval of progression to metastatic castration-resistant prostate cancer.

Lymphoepithelioma-Like Carcinoma of the Urinary Bladder

June 15, 2015

A 65-year-old woman presented to a local emergency department complaining of right flank pain that had worsened over the past 10 days. A CT scan of the abdomen and pelvis showed intravesical tumors of the urinary bladder.

Subacute Headache in a Patient With Metastatic Gastric Cancer

May 15, 2015

A 59-year-old man with metastatic gastric cancer presented to the oncology clinic with a 1-week history of positional headache, nausea, and vomiting. He stated that the headache was located in the frontal region, was 8 on a scale of 10 in intensity.

ADT Risks and Side Effects in Advanced Prostate Cancer: Cardiovascular and Acute Renal Injury

January 15, 2015

This article reviews recent evidence suggesting an increased risk of pneumonia, cardiovascular disease, and acute kidney injury in men treated with ADT and consider whether the incidence of such events differs with the treatment modality.

Small Steps That Lead to a Giant Leap for Prostate Cancer Patients

August 15, 2014

In the past 5 years we have taken at least 7 steps forward for men with prostate cancer-which hopefully will turn into “one giant leap” in our attempt to convert advanced prostate cancer into a chronic disease.

New Biomarkers in Prostate Cancer

February 15, 2014

In this article, we review recent advances in the discovery of prostate cancer biomarkers, their integration into clinical practice, and implications for improving clinical management of the disease.

Rising PSA Level in a 46-Year-Old Man

May 15, 2013

A 46-year-old man sought consultation for an abnormal prostate-specific antigen (PSA) level of 9 ng/mL and one prior negative biopsy. Five months ago, while traveling, he had presented to an urgent care facility with a 24-hour history of fever, chills, nausea, and vomiting.